Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease
Clinical trial NCT00408928 · COMPLETED
Trial details
- NCT number
- NCT00408928
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.